Formulation and Drug Delivery

Focusing on the Patient in Drug Development

June 03, 2022

Putting the patient at the forefront of drug development is essential, particularly to ensure medication compliance is optimized.

Development of Coprocessed Excipients

June 03, 2022

The right processes used with the right excipient combinations address evolving formulation needs.

Connecting the Dots for Pharma

June 02, 2022

The inaugural Connect in Pharma event will take place on 14 and 15 September in Geneva, Switzerland.

Vaxzevria Gains Approval in EU as a Third Dose COVID-19 Booster in Adults

May 24, 2022

AstraZeneca's recombinant COVID-19 vaccine, originally invented by the University of Oxford, has been approved as a third dose booster vaccine in the EU.

EMA Recommends Approval of Niemann-Pick Disease Types A/B and B Therapy

May 24, 2022

EMA has recommended the marketing authorization of Xenpozyme (olipudase alfa) in the European Union.

Manufacturing OSD Forms: Key Trends Shaping the Industry

May 16, 2022

The latest manufacturing technologies are essential for helping pharmaceutical formulators meet up-and-coming trends in OSD treatments.

Plan Early: Optimizing Stability During Lyophilization

May 15, 2022

The need for sustainability and early considerations of a lyophilization strategy grow more pertinent on the back of growing biologics volume.

Opportunities for Growth and Breakthroughs for Cell and Gene Therapies

May 15, 2022

CGTs offer hope for the future of treatments, but the costly manufacturing, slow turnaround time, and need for supplies hinder progress.

Converting Injectable Therapies to Combination Drug-Device Products

May 15, 2022

The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices.

FDA Limits Use of Janssen COVID-19 Vaccine

May 06, 2022

FDA is limiting the use of Janssen’s COVID-19 vaccine to certain individuals.